• The New Money
  • Posts
  • Marvell's Mega Deal, Peptides In America, And A Gigawatt Of Fuel Cells In California

Marvell's Mega Deal, Peptides In America, And A Gigawatt Of Fuel Cells In California

The markets and trends that matter, made simple. Discover what’s next.

Marvell Technology Is Acquiring Lumentum In $115 Billion Deal

Marvell Technology (NASDAQ: MRVL) entered into a definitive agreement to acquire Lumentum (NASDAQ: LITE) in an all stock deal valued at approximately $115 billion, marking Marvell’s largest acquisition in compan history. Lumentum is one of the largest producers of indium-phosphide lasers used in artificial intelligence data centres.

Enhanced Group Launches Access To More Peptides In America

Enhanced Group (NYSE: ENHA) launched access to six additional peptides through licensed clinicians, which are currently available to be prescribed to adults in the United States, with eligibility varying on a state by state basis. Billionaire investor and entrepreneur Christian Angermayer previously made waves when he led a $50 million financing round into Enhanced Group through his family office Apeiron Investment Group.

Bloom Energy And California Resources Are Exploring A Fuel Cell Project 

Bloom Energy (NYSE: BE) and California Resources (NYSE: CRC) entered into a new non-binding deal to explore deploying 1 gigawatt of Bloom Energy’s solid-oxide fuel cell power with carbon capture in California.

There’s A New Opportunity In Mobile Power Infrastructure

Electricity demand in North America is growing faster than the grid can expand. Which is exactly why NOMAD Power Solutions (NASDAQ: NMAD) is deploying mobile energy infrastructure that can be used by utilities, oil and gas operators, EV charging networks and data centres.

The Sprint

Looking to connect? Reach out and get in touch.

New here? Join our community of 100,000+ individuals interested in uncovering the world’s most exciting early stage companies.

Disclaimer: The New Money provides background information on early stage companies from publicly available sources. The New Money provides no advice on dealing in securities, is not a financial adviser and does not pretend to be so. This message is meant for information and educational purposes only. The information contained in this email is not to be considered factual or complete. Anybody interested in obtaining financial and other information on companies mentioned is advised to get it direct from the companies, or from their own investment adviser. The New Money does not intend for this information to be used to inform an investment decision. The New Money has been compensated by some of the companies mentioned in this email for awareness campaigns, which affects our ability to be unbiased. The Principals of The New Money may buy or sell shares of the mentioned companies without further notice. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities. The New Money and its principals and agents are not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Always do your own research and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment. Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy or Sell securities. No representation is being made that any stock trade will or is likely to achieve profits. Comparisons made to other featured companies or past performance is not indicative of future results.